Pulmatrix (PULM), Cipla Technologies Enter Agreement for Development and Commercialization of Pulmazole Apr 15, 2019 09:10AM
Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of Pulmazole™ Apr 15, 2019 09:00AM
Pulmatrix Enters Into Binding Term Sheet with Cipla Technologies LLC for the Development and Commercialization of Pulmazole Apr 1, 2019 09:00AM
Pulmatrix Initiates European Pilot Bioequivalence Study of PUR0200 for COPD Feb 1, 2016 07:30AM
Pulmatrix, Inc. (Nasdaq: PULM) to Ring the Nasdaq Stock Market Opening Bell Dec 22, 2015 07:30AM


Dec 8, 2015 08:12AM Pulmatrix (PULM) Names New Chairman
Dec 8, 2015 08:00AM Pulmatrix Appoints Mark Iwicki Chairman of the Board
Oct 8, 2015 08:00AM Study: Pulmatrix's PUR1900 Inhaled Cystic Fibrosis Drug Demonstrates High Lung Retention and Potency Against Fungal Infection
Oct 1, 2015 08:00AM NIH Awards $1.7 Million Grant for Celdara Medical and Pulmatrix to Develop an Inhaled Biologic Treatment for Idiopathic Pulmonary Fibrosis
Sep 11, 2015 08:00AM Pulmatrix to Highlight PUR1900 Data at 2015 North American Cystic Fibrosis Conference